Core Viewpoint - He Eye Hospital (301103) expects a net profit attributable to shareholders of 24 million to 36 million for 2025, representing a year-on-year growth of 187.60% to 231.40% [1] Group 1: Performance Improvement - The company has achieved a turnaround from loss to profit during the reporting period, driven by business structure optimization, effective cost control, and the disposal of inefficient assets [1] - Significant enhancement in profitability is attributed to the continuous optimization of the business structure, with a focus on high-margin refractive and optical businesses [1] Group 2: Cost and Efficiency Management - The company has implemented refined operational management, achieving cost reduction and efficiency improvement through centralized procurement optimization, supply chain efficiency enhancement, and digital operations [1] - These measures have contributed to the overall improvement in profitability [1] Group 3: Asset Optimization - The company has actively integrated, adjusted, or divested certain business units that have long-term poor performance or weak strategic synergy, further optimizing asset allocation efficiency [1]
何氏眼科：预计2025全年盈利2400万至3600万，得益于业务结构优化、成本费用有效控制及低效资产出清